Large-scale synthesis of a Notum inhibitor employing a modified Sakai reaction as the key step

WuXi AppTec scientists recently contributed to a research article in the Royal Society of Chemistry describing the large-scale synthesis of a potent and selective inhibitor of Notum carboxylesterase (an enzyme that suppresses Wnt signaling pathways).  By employing a modified Sakai reaction as the key step, a one-pot synthesis of this Notum inhibitor was developed, enabling the delivery of multi-gram quantities for use in preclinical toxicology studies.

https://pubmed.ncbi.nlm.nih.gov/36275171/



Large-scale synthesis of a Notum inhibitor employing a modified Sakai reaction as the key step

Download

← Return to Resources

Related Content

Cereblon (CRBN) forms an E3 ligase complex together with DDB1, CUL4, and RBX1. CRBN functions as a substrate receptor of...

VIEW RESOURCE

Animal studies may provide a close approximation to humans when addressing the key challenge of clinical translatability. In the preclinical...

VIEW RESOURCE
← View all Cardiovascular & Metabolic Diseases Resources
× peptide, amino acid

Contact An Expert Today!